CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today announced, as required under NASDAQ Listing Rule 5635(c)(4), that the Company has approved an option grant as inducement for the hire of Arthur Tzianabos, Ph.D., as Chief Scientific Officer. This option grant, as well as an open market purchase of OvaScience stock by Dr. Tzianabos on September 12, 2013, was reported on Form 4s filed with the Securities and Exchange Commission.
Help employers find you! Check out all the jobs and post your resume.
